期刊
BLOOD CELLS MOLECULES AND DISEASES
卷 29, 期 3, 页码 418-432出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1006/bcmd.2002.0596
关键词
-
类别
资金
- NCRR NIH HHS [RR 00833] Funding Source: Medline
- NIDDK NIH HHS [DK 53505-02] Funding Source: Medline
We undertook a three-year screening program for mutations of the HFE gene among 41,000 subjects attending the Kaiser Permanente Health Appraisal Center in San Diego, California. Our results show that the C282Y and H63D mutations of the HFE gene associated with hemochromatosis have measurable and consistent effects on iron indicators and are associated with liver disorders, but have no measurable effect on other iron overload-related symptoms and life-expectancy. The very low clinical penetrance of the HFE mutations must be taken into account in calculating cost/benefit and risk/benefit ratios in screening for hemochromatosis. (C) 2002 Elsevier Science (USA).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据